ZENATANE (isotretinoin)
RETINOIDS AND DERIVATIVES (SYSTEMIC)·SEVERE RECALCITRANT NODULAR ACNE
BLUEPOINT LABOR
Indication
Severe recalcitrant nodular acne
Severe recalcitrant nodular acne is an advanced, treatment-resistant subtype of acne vulgaris affecting the pilosebaceous units of the skin, most frequently involving the face, chest, and back in adolescents and adults. Read more about Severe recalcitrant nodular acne
19 drugs 16 manufacturers
Drugs that treat it
Common Severe recalcitrant nodular acne therapies.
Filter & compare in the drug finder →Opens the drug finder with Severe recalcitrant nodular acne preselected.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonSevere recalcitrant nodular acne is an advanced, treatment-resistant subtype of acne vulgaris affecting the pilosebaceous units of the skin, most frequently involving the face, chest, and back in adolescents and adults.
It is clinically characterized by widespread, painful, deep-seated inflammatory nodules measuring 5 millimeters or greater in diameter, often accompanied by extensive erythema, cyst-like lesions, and substantial tissue destruction that poses a severe risk of permanent scarring.
Pathophysiologically driven by follicular hyperkeratinization, excess sebum production, and intense immune-mediated inflammation surrounding *Cutibacterium acnes*, the condition is designated recalcitrant due to its persistent failure to improve under conventional systemic antibacterial and topical therapies.
- nih.gov
Severe recalcitrant nodular acne is an advanced, treatment-resistant subtype of acne vulgaris affecting the pilosebaceous units of the skin, most frequently involving the face, chest, and back in adolescents and adults
- fda.gov
Severe recalcitrant nodular acne is an advanced, treatment-resistant subtype of acne vulgaris affecting the pilosebaceous units of the skin, most frequently involving the face, chest, and back in adolescents and adults
- nih.gov
It is clinically characterized by widespread, painful, deep-seated inflammatory nodules measuring 5 millimeters or greater in diameter, often accompanied by extensive erythema, cyst-like lesions, and substantial tissue destruction that poses a severe risk of permanent scarring Pathophysiologically driven by follicular hyperkeratinization, excess sebum production, and intense immune-mediated inflammation surrounding *Cutibacterium acnes*, the condition is designated recalcitrant due to its persis...
- theskindoctor.melbourne
It is clinically characterized by widespread, painful, deep-seated inflammatory nodules measuring 5 millimeters or greater in diameter, often accompanied by extensive erythema, cyst-like lesions, and substantial tissue destruction that poses a severe risk of permanent scarring
- cosmoderma.org
Pathophysiologically driven by follicular hyperkeratinization, excess sebum production, and intense immune-mediated inflammation surrounding *Cutibacterium acnes*, the condition is designated recalcitrant due to its persistent failure to improve under conventional systemic antibacterial and topical therapies
Personalize your experience
Follow Severe recalcitrant nodular acne and get updates as they land.
Create a free account
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.